Home/Filings/4/0001209191-24-003787
4//SEC Filing

Wong Hing C 4

Accession 0001209191-24-003787

CIK 0001828673other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 2:24 PM ET

Size

4.9 KB

Accession

0001209191-24-003787

Insider Transaction Report

Form 4
Period: 2024-02-20
Wong Hing C
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Common Stock

    2024-02-20$1.40/sh+739,288$1,035,00316,054,156 total
Footnotes (1)
  • [F1]The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended.

Issuer

HCW Biologics Inc.

CIK 0001828673

Entity typeother

Related Parties

1
  • filerCIK 0001866258

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 2:24 PM ET
Size
4.9 KB